Asthma is a severe and growing threat affecting both children and adults in both developing and developed world, currently affecting approximately 8% of US population. It is becoming increasingly recognized as a syndrome constituted by airway obstruction, airway hyperresponsiveness, and airway inflammation with different causes, associated risk factors, and underlying pathophysiology. The advances in basic and clinical research of asthma have accelerated over the past 20 years with increasing diagnostic tools, especially biomarkers, that led to specific characterization of individual patient's asthma pathophysiology, or disease ""phenotype"" and ""endotype,"" which allowed precision medicine therapies, including new asthma biologics. This b...
Asthma is a very heterogeneous disease and since early childhood many classifications have been prop...
Introduction: Asthma is a complex disease with heterogeneity in etiology, triggers, clinical charact...
Asthma is a heterogeneous condition, but firm identification of heterogeneity-focused treatments is ...
Introduction: The development of biologic molecules led to a drastic change in the therapeutic appro...
The concept of asthma has changed from that of a single disease entity to that of a heterogeneous di...
wheezing and increased airway responsiveness to a variety of environmental stimuli. The definition o...
Purpose of review Target therapy is the necessary step towards personalized medicine. The definition...
Despite the development of novel treatments, improvement in the design of delivery devices, and new ...
Asthma is a heterogeneous disease characterized by bronchial hyperreactivity, chronic airway inflamm...
Asthma, a common, non-communicable chronic disease affects over 300 million individuals worldwide. T...
Discoveries from basic science research in the last decade have brought significant progress in know...
A new online module discusses the concepts of ‘phenotype’ and ‘endotype’ in asthma. Asthma is an umb...
AbstractDiscoveries from basic science research in the last decade have brought significant progress...
According to the current guidelines, severe asthma still represents a controversial topic in terms o...
Asthma is a heterogeneous disease mainly affecting the lower airways and hallmarked by a chronic lun...
Asthma is a very heterogeneous disease and since early childhood many classifications have been prop...
Introduction: Asthma is a complex disease with heterogeneity in etiology, triggers, clinical charact...
Asthma is a heterogeneous condition, but firm identification of heterogeneity-focused treatments is ...
Introduction: The development of biologic molecules led to a drastic change in the therapeutic appro...
The concept of asthma has changed from that of a single disease entity to that of a heterogeneous di...
wheezing and increased airway responsiveness to a variety of environmental stimuli. The definition o...
Purpose of review Target therapy is the necessary step towards personalized medicine. The definition...
Despite the development of novel treatments, improvement in the design of delivery devices, and new ...
Asthma is a heterogeneous disease characterized by bronchial hyperreactivity, chronic airway inflamm...
Asthma, a common, non-communicable chronic disease affects over 300 million individuals worldwide. T...
Discoveries from basic science research in the last decade have brought significant progress in know...
A new online module discusses the concepts of ‘phenotype’ and ‘endotype’ in asthma. Asthma is an umb...
AbstractDiscoveries from basic science research in the last decade have brought significant progress...
According to the current guidelines, severe asthma still represents a controversial topic in terms o...
Asthma is a heterogeneous disease mainly affecting the lower airways and hallmarked by a chronic lun...
Asthma is a very heterogeneous disease and since early childhood many classifications have been prop...
Introduction: Asthma is a complex disease with heterogeneity in etiology, triggers, clinical charact...
Asthma is a heterogeneous condition, but firm identification of heterogeneity-focused treatments is ...